Eton Pharmaceuticals Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags [Yahoo! Finance]
Eton Pharmaceuticals, Inc. (ETON)
Last eton pharmaceuticals, inc. earnings: 3/5 04:02 pm
Check Earnings Report
Company Research
Source: Yahoo! Finance
US$0.15 loss per share (further deteriorated from US$0.036 loss in FY 2023). All figures shown in the chart above are for the trailing 12 month (TTM) period Revenue exceeded analyst estimates by 2.9%. Earnings per share (EPS) missed analyst estimates by 18%. Looking ahead, revenue is forecast to grow 30% p.a. on average during the next 3 years, compared to a 8.4% growth forecast for the Pharmaceuticals industry in the US. Performance of the American Pharmaceuticals industry. The company's shares are up 4.1% from a week ago. We don't want to rain on the parade too much, but we did also find 1 warning sign for Eton Pharmaceuticals that you need to be mindful of. Have feedback on this article? Concerned about the content? Get in touch
Read more
Impact Snapshot
Event Time:
ETON
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ETON alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ETON alerts
High impacting Eton Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
ETON
News
- Eton Pharmaceuticals, Inc. (NASDAQ: ETON) had its price target raised by analysts at Craig Hallum from $23.00 to $26.00. They now have a "buy" rating on the stock.MarketBeat
- Eton Pharmaceuticals, Inc. (NASDAQ: ETON) had its "buy" rating re-affirmed by analysts at B. Riley. They now have a $24.00 price target on the stock, up previously from $21.00.MarketBeat
- Eton Pharmaceuticals, Inc. (NASDAQ: ETON) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $33.00 price target on the stock.MarketBeat
- Eton Pharmaceuticals Reports Fourth Quarter 2024 Financial ResultsGlobeNewswire
- Eton Pharmaceuticals Announces Positive Pivotal Clinical Study Results for Product Candidate ET-600GlobeNewswire
ETON
Earnings
- 3/18/25 - Miss
ETON
Sec Filings
- 3/18/25 - Form 8-K
- 3/18/25 - Form 8-K
- 3/18/25 - Form 10-K
- ETON's page on the SEC website